Sharon Shacham

2014

In 2014, Sharon Shacham earned a total compensation of $534.3K as President and Chief Scientific Officer at Karyopharm Therapeutics, a 93% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$138,500
Salary$385,000
Other$10,820
Total$534,320

Shacham received $385K in salary, accounting for 72% of the total pay in 2014.

Shacham also received $138.5K in non-equity incentive plan and $10.8K in other compensation.

Rankings

In 2014, Sharon Shacham's compensation ranked 10,058th out of 13,032 executives tracked by ExecPay. In other words, Shacham earned more than 22.8% of executives.

ClassificationRankingPercentile
All
10,058
out of 13,032
23rd
Division
Manufacturing
3,823
out of 4,966
23rd
Major group
Chemicals And Allied Products
1,312
out of 1,686
22nd
Industry group
Drugs
1,048
out of 1,365
23rd
Industry
Pharmaceutical Preparations
806
out of 1,043
23rd
Source: SEC filing on April 29, 2016.

Shacham's colleagues

We found four more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2014.

2014

Justin Renz

Karyopharm Therapeutics

Chief Financial Officer

2014

Ran Frenkel

Karyopharm Therapeutics

Executive Vice President, Worldwide Development Operations

2014

Christopher Primiano

Karyopharm Therapeutics

General Counsel

2014

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

News

You may also like